熱門資訊> 正文
Jaguar Health GAAP EPS of -$4.04 misses by $2.84, revenue of $2.72M misses by $0.71M
2024-08-13 20:06
- Jaguar Health press release (NASDAQ:JAGX): Q2 GAAP EPS of -$4.04 misses by $2.84.
- Revenue of $2.72M (+1.5% Y/Y) misses by $0.71M.
- Non-GAAP recurring EBITDA for the second quarter of 2024 and the second quarter of 2023 were a net loss of $8.8 million and $7.7 million, respectively.
More on Jaguar Health
- Jaguar stock plunges 60% on failed Phase 3 study for crofelemer
- Jaguar Health slips after update on anti-diarrheal therapy
- Seeking Alpha’s Quant Rating on Jaguar Health
- Historical earnings data for Jaguar Health
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
